Cover
Cover - USD ($) | 12 Months Ended | ||
Jan. 31, 2018 | Dec. 01, 2020 | Jul. 31, 2017 | |
Cover [Abstract] | |||
Entity Registrant Name | CICLET HOLDINGS INC. | ||
Entity Central Index Key | 0001699126 | ||
Document Type | 10-K | ||
Amendment Flag | false | ||
Entity Voluntary Filers | No | ||
Current Fiscal Year End Date | --01-31 | ||
Entity Well Known Seasoned Issuer | No | ||
Entity Small Business | true | ||
Entity Shell Company | true | ||
Entity Emerging Growth Company | true | ||
Entity Current Reporting Status | Yes | ||
Document Period End Date | Jan. 31, 2018 | ||
Entity Filer Category | Non-accelerated Filer | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2018 | ||
Entity Ex Transition Period | false | ||
Entity Common Stock Shares Outstanding | 15,851,001 | ||
Entity Public Float | $ 0 | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Entity Interactive Data Current | Yes |
BALANCE SHEETS
BALANCE SHEETS - USD ($) | Jan. 31, 2018 | Jan. 31, 2017 |
Current Assets | ||
Cash | $ 35,396 | $ 503 |
Funds held in trust | 3,943 | 11,310 |
Total Current Assets | 39,339 | 11,813 |
TOTAL ASSETS | 39,339 | 11,813 |
Current Liabilities | ||
Accounts payable and accrued liabilities | 18,512 | 0 |
Due to related party | 2,907 | 999 |
Total Current Liabilities | 21,419 | 999 |
Total Liabilities | 21,419 | 999 |
STOCKHOLDERS' EQUITY | ||
Common Stock:175,000,000 shares authorized; 15,851,001 and 10,000,000 shares, respectively issued and outstanding with par value of $0.00001 each | 159 | 100 |
Additional paid-in capital | 54,948 | 19,900 |
Accumulated deficit | (37,187) | (9,186) |
Total Stockholders' Equity | 17,920 | 10,814 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 39,339 | $ 11,813 |
BALANCE SHEETS (Parenthetical)
BALANCE SHEETS (Parenthetical) - $ / shares | Jan. 31, 2018 | Jan. 31, 2017 |
BALANCE SHEETS | ||
Common Stock, par value | $ 0.00001 | $ 0.00001 |
Common Stock,shares authorized | 175,000,000 | 175,000,000 |
Common Stock, share issued | 15,851,001 | 10,000,000 |
Common Stock, share outstanding | 15,851,001 | 10,000,000 |
STATEMENTS OF OPERATIONS AND CO
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) | 7 Months Ended | 12 Months Ended |
Jan. 31, 2017 | Jan. 31, 2018 | |
OPERATING EXPENSES | ||
Professional fees | $ 5,705 | $ 25,203 |
General and administrative | 3,481 | 2,798 |
Total Operating Expenses | 9,186 | 28,001 |
NET LOSS AND COMPREHENSIVE LOSS | $ (9,186) | $ (28,001) |
Basic and diluted loss per share | $ 0 | $ 0 |
Basic and diluted weighted average number of common shares outstanding | 10,000,000 | 10,778,741 |
STATEMENTS OF CHANGES IN STOCKH
STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($) | Total | Common Stock | Additional Paid-in Capital | Accumulated Deficit |
Balance, shares at Jun. 30, 2016 | ||||
Balance, amount at Jun. 30, 2016 | $ 0 | $ 0 | $ 0 | $ 0 |
Issuance of common stock for cash, shares | 10,000,000 | |||
Issuance of common stock for cash, amount | 20,000 | $ 100 | 19,900 | 0 |
Net loss | (9,186) | $ 0 | 0 | (9,186) |
Balance, shares at Jan. 31, 2017 | 10,000,000 | |||
Balance, amount at Jan. 31, 2017 | $ 10,814 | $ 100 | 19,900 | (9,186) |
Issuance of common stock for cash, shares | 5,851,001 | 5,851,001 | ||
Issuance of common stock for cash, amount | $ 35,107 | $ 59 | 35,048 | 0 |
Net loss | (28,001) | $ 0 | 0 | (28,001) |
Balance, shares at Jan. 31, 2018 | 15,851,001 | |||
Balance, amount at Jan. 31, 2018 | $ 17,920 | $ 159 | $ 54,948 | $ (37,187) |
STATEMENTS OF CASH FLOWS
STATEMENTS OF CASH FLOWS - USD ($) | 7 Months Ended | 12 Months Ended |
Jan. 31, 2017 | Jan. 31, 2018 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net loss | $ (9,186) | $ (28,001) |
Changes in operating assets and liabilities: | ||
Accounts payable and accrued liabilities | 0 | 18,512 |
Net cash used in operating activities | (9,186) | (9,489) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from issuance of common shares | 20,000 | 35,107 |
Advances from related party | 999 | 1,908 |
Net cash provided by financing activities | 20,999 | 37,015 |
Net increase in cash and cash equivalents | 11,813 | 27,526 |
Cash and cash equivalents - beginning of period | 0 | 11,813 |
Cash and cash equivalents - end of period | 11,813 | 39,339 |
Cash consists of: | ||
Cash | 503 | 35,396 |
Funds held in trust | 11,310 | 3,943 |
Net | 11,813 | 39,339 |
Supplemental Cash Flow Disclosures | ||
Cash paid for interest | 0 | 0 |
Cash paid for income taxes | $ 0 | $ 0 |
NATURE OF BUSINESS
NATURE OF BUSINESS | 12 Months Ended |
Jan. 31, 2018 | |
NATURE OF BUSINESS | |
NOTE 1 - NATURE OF BUSINESS | Ciclet Holdings Inc. (the “Company”) is a start-up company with a primary focus on developing software applications for location-based service (LBS) that uses location data to control features. The Company was incorporated in the State of Nevada on June 30, 2016. The Company’s operational office is in the Philippines. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Jan. 31, 2018 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | Basis of Presentation The financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These consolidated financial statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles (“GAAP”) of the United States. Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. Cash Cash comprises cash balances, cash on current accounts with banks, and bank deposits. As of January 31, 2018 and 2017, the Company has $35,396 and $0, respectively, in cash. The cash accounts are held in Philippine Pesos, and foreign exchange loss has been recorded, which is an insignificant amount as of January 31, 2018. Funds held in trust comprise funds held in a trust account by the Company’s legal counsel. As of January 31, 2018, the Company has $3,943 in funds held in trust, which are also considered cash equivalent. Related Parties The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions (see Note 5). Basic and Diluted Income (Loss) Per Share The Company computes income (loss) per share in accordance with FASB ASC 260, “Earnings per Share,” which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. No potentially dilutive debt or equity instruments were issued or outstanding as of January 31, 2018 or 2017. Software Development Costs In accordance with FASB ASC 985 “Software,” all software development costs are expensed prior to the establishment of technological feasibility. Technological feasibility of a software is established upon the completion of all planning, designing, coding and testing activities required to establish to meet its design specifications. Software development costs are capitalized after the determination of technological feasibility. These costs include coding and testing performed subsequent to establishing technological feasibility. When the software is fully developed and reached its implementation stage, cost of maintenance and customer support will be charged to expense when related revenue is recognized or when those costs are incurred, whichever occurs first. No software development costs have been incurred up to January 31, 2018. Financial Instruments The Company’s financial instruments consist of cash and due to shareholder. The carrying amount of such approximate their fair value due to the short maturity of the instrument. Fair Value Measurement ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosure of the fair value of financial instruments held by the Company. ASC topic 825, “Financial Instruments,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels of valuation hierarchy are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 – to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement. Revenue Recognition The Company recognizes revenue in the statement of operations when the following criteria are met in accordance with ASC 605, “Revenue Recognition:” there is persuasive evidence of an arrangement exists; the price is fixed and determinable; delivery has occurred or services have been rendered, and collectability is reasonably assured. The Company has not recognized any revenue since its inception. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when a different tax rate is enacted. Pursuant to the provisions of ASC No. 740, “Income Taxes,” the Company provides valuation allowances for deferred tax assets for which it does not consider realization of such assets to be more likely than not. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the historical taxable income generation, projected future taxable income, the reversal of existing deferred tax liabilities and tax planning strategies in making this assessment (see Note 6). Recent Accounting Pronouncements In August, 2015, the FASB issued ASU No. 2015-04, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date. The amendment in this ASI defers the effective date of ASI No. 2014-09 for all entities for one year. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in ASU 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 31, 2016, including interim reporting periods within that reporting period. The Company does not believe the adoption of this ASU will have a significant impact on the financial statements. In January 2016, the FASB issued ASU 2016-01, “Financial Instruments Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities,” which addresses the recognition, measurement, presentation and disclosure of financial assets and liabilities. The ASU primarily affects the accounting for equity investments, financial liabilities under the fair value option and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The ASU is effective for public companies for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the adoption of this ASU will have a significant impact on the financial statements. |
GOING CONCERN
GOING CONCERN | 12 Months Ended |
Jan. 31, 2018 | |
GOING CONCERN | |
NOTE 3 - GOING CONCERN | These audited financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. During the year ended January 31, 2018, the Company recognized no sales revenue and incurred a net loss of $28,001. As of January 31, 2018, the Company had an accumulated deficit of $37,187. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholder, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company’s future business. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. |
COMMON STOCK
COMMON STOCK | 12 Months Ended |
Jan. 31, 2018 | |
COMMON STOCK | |
NOTE 4 - COMMON STOCK | The Company has authorized 175,000,000 shares of common stock with a par value of $0.00001. During the year ended January 31, 2018, the Company issued 5,851,001 common shares at $0.006 per share for proceeds of $35,107 to independent investors through private placement. On June 30, 2016, the Company received an initial funding of $20,000 through the sale of common stock to our sole officer and director, who purchased 10,000,000 of our common stock at $0.002 per share for $20,000. As of January 31, 2018 and January 31, 2017, the Company’s common stock issued and outstanding was 115,851,001 shares and 10,000,000 shares, respectively. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 12 Months Ended |
Jan. 31, 2018 | |
RELATED PARTY TRANSACTIONS | |
NOTE 5 - RELATED PARTY TRANSACTIONS | The amount due to related party consists of advances from the Company’s director. The amounts are non-interest bearing, have no set repayment terms and are not secured. During the periods ended January 31, 2018 and 2017, the director advanced the Company $1,908 and $999, respectively. As of January 31, 2018 and January 31, 2017, the amount owing to the related party was $2,907 and $999, respectively. |
INCOME TAX
INCOME TAX | 12 Months Ended |
Jan. 31, 2018 | |
INCOME TAX | |
NOTE 6 - INCOME TAX | The Company did not provide any current or deferred U.S. federal income tax provision or benefit for any of the periods presented because the Company has experienced operating losses for U.S. federal income tax purposes since inception. When it is more likely than not that a tax asset cannot be realized through future income the Company must allow for this future tax benefit On December 22, 2017, the United States enacted the Tax Cuts and Jobs Act (the “ Act January 31, 2018 January 31, 2017 Net operating loss carryforward $ 37,187 $ 9,186 Tax Rate 21 % 21 % Deferred tax asset 7,809 1,929 Less: Valuation allowance (7,809 ) (1,929 ) Deferred tax asset $ - $ - The Company’s deferred tax asset has been fully offset by a valuation allowance, which increased by $5,880 and $1,929 during the periods ended January 31, 2018 and 2017, respectively. As of January 31, 2018, the Company had $37,187 of the U.S. net operating losses (the “U.S. NOLs”), which begin to expire between 2037 and 2038. NOLs generated in tax years prior to January 31, 2018, can be carried forward for twenty years, whereas NOLs generated after January 31, 2018 can be carried forward indefinitely. In accordance with Section 382 of the U.S. Internal Revenue Code, the usage of the Company’s net operating loss carry forwards is subject to annual limitations following greater than 50% ownership changes. Tax returns for the years ended 2017 through 2018 are subject to review by the tax authorities. |
RISKS AND UNCERTAINTIES
RISKS AND UNCERTAINTIES | 12 Months Ended |
Jan. 31, 2018 | |
RISKS AND UNCERTAINTIES | |
NOTE 7 - RISKS AND UNCERTAINTIES | In early 2020, the World Health Organization declared the rapidly spreading coronavirus disease (COVID-19) outbreak a pandemic. This pandemic has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no retroactive material adverse impacts on the Company’s results of operations and financial position at January 31, 2018. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company in the future. The Company is not 10 may |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Jan. 31, 2018 | |
SUBSEQUENT EVENTS | |
NOTE 8 - SUBSEQUENT EVENTS | Management has evaluated subsequent events through the date these financial statements were issued. Based on our evaluation no other material events have occurred that require disclosure. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Jan. 31, 2018 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Basis of Presentation | The financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These consolidated financial statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles (“GAAP”) of the United States. |
Use of Estimates | The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. |
Related Parties | The amount due to related party consists of advances from the Company’s director. The amounts are non-interest bearing, have no set repayment terms and are not secured. During the periods ended January 31, 2018 and 2017, the director advanced the Company $1,908 and $999, respectively. As of January 31, 2018 and January 31, 2017, the amount owing to the related party was $2,907 and $999, respectively. |
Cash | Cash comprises cash balances, cash on current accounts with banks, and bank deposits. As of January 31, 2018 and 2017, the Company has $35,396 and $0, respectively, in cash. The cash accounts are held in Philippine Pesos, and foreign exchange loss has been recorded, which is an insignificant amount as of January 31, 2018. Funds held in trust comprise funds held in a trust account by the Company’s legal counsel. As of January 31, 2018, the Company has $3,943 in funds held in trust, which are also considered cash equivalent. |
Basic and Diluted Income (Loss) Per Share | The Company computes income (loss) per share in accordance with FASB ASC 260, “Earnings per Share,” which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. No potentially dilutive debt or equity instruments were issued or outstanding as of January 31, 2018 or 2017. |
Software Development Costs | In accordance with FASB ASC 985 “Software,” all software development costs are expensed prior to the establishment of technological feasibility. Technological feasibility of a software is established upon the completion of all planning, designing, coding and testing activities required to establish to meet its design specifications. Software development costs are capitalized after the determination of technological feasibility. These costs include coding and testing performed subsequent to establishing technological feasibility. When the software is fully developed and reached its implementation stage, cost of maintenance and customer support will be charged to expense when related revenue is recognized or when those costs are incurred, whichever occurs first. No software development costs have been incurred up to January 31, 2018. |
Financial Instruments | The Company’s financial instruments consist of cash and due to shareholder. The carrying amount of such approximate their fair value due to the short maturity of the instrument. |
Fair Value Measurement | ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosure of the fair value of financial instruments held by the Company. ASC topic 825, “Financial Instruments,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels of valuation hierarchy are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 – to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement. |
Revenue Recognition | The Company recognizes revenue in the statement of operations when the following criteria are met in accordance with ASC 605, “Revenue Recognition:” there is persuasive evidence of an arrangement exists; the price is fixed and determinable; delivery has occurred or services have been rendered, and collectability is reasonably assured. The Company has not recognized any revenue since its inception. |
Income Taxes | Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when a different tax rate is enacted. Pursuant to the provisions of ASC No. 740, “Income Taxes,” the Company provides valuation allowances for deferred tax assets for which it does not consider realization of such assets to be more likely than not. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the historical taxable income generation, projected future taxable income, the reversal of existing deferred tax liabilities and tax planning strategies in making this assessment (see Note 6). |
Recent Accounting Pronouncements | In August, 2015, the FASB issued ASU No. 2015-04, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date. The amendment in this ASI defers the effective date of ASI No. 2014-09 for all entities for one year. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in ASU 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 31, 2016, including interim reporting periods within that reporting period. The Company does not believe the adoption of this ASU will have a significant impact on the financial statements. In January 2016, the FASB issued ASU 2016-01, “Financial Instruments Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities,” which addresses the recognition, measurement, presentation and disclosure of financial assets and liabilities. The ASU primarily affects the accounting for equity investments, financial liabilities under the fair value option and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The ASU is effective for public companies for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the adoption of this ASU will have a significant impact on the financial statements. |
INCOME TAX (Table)
INCOME TAX (Table) | 12 Months Ended |
Jan. 31, 2018 | |
INCOME TAX | |
Schedule of income tax | January 31, 2018 January 31, 2017 Net operating loss carryforward $ 37,187 $ 9,186 Tax Rate 21 % 21 % Deferred tax asset 7,809 1,929 Less: Valuation allowance (7,809 ) (1,929 ) Deferred tax asset $ - $ - |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | Jan. 31, 2018 | Jan. 31, 2017 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||
Cash | $ 35,396 | $ 0 |
Funds held in trust | $ 3,943 | $ 11,310 |
GOING CONCERN (Details Narrativ
GOING CONCERN (Details Narrative) - USD ($) | 7 Months Ended | 12 Months Ended | |
Jan. 31, 2017 | Jan. 31, 2017 | Jan. 31, 2018 | |
GOING CONCERN | |||
Accumulated Deficit | $ (9,186) | $ (9,186) | $ (37,187) |
NET LOSS | $ (9,186) | $ (9,186) | $ (28,001) |
COMMON STOCK (Details Narrative
COMMON STOCK (Details Narrative) - USD ($) | 7 Months Ended | 12 Months Ended |
Jan. 31, 2017 | Jan. 31, 2018 | |
Common Stock, share authorized | 175,000,000 | 175,000,000 |
Common Stock, par value | $ 0.00001 | $ 0.00001 |
Common Stock, share issued | 10,000,000 | 15,851,001 |
Common Stock, share outstanding | 10,000,000 | 15,851,001 |
Proceeds from issuance of common shares | $ 20,000 | $ 35,107 |
Stock issued during period shares, new issues | 5,851,001 | |
Stock issued during period per share , new issues | $ 0.006 | |
Common Stock, share amount | $ 100 | $ 159 |
Officer and director [Member] | June 30, 2016 [Member] | ||
Initial funding | $ 20,000 | |
Common Stock, share purchased | 10,000,000 | |
Common stock issued price per share | $ 0.002 | |
Common Stock, share amount | $ 20,000 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) | 7 Months Ended | 12 Months Ended |
Jan. 31, 2017 | Jan. 31, 2018 | |
Due to related party | $ 999 | $ 2,907 |
Advances from related party | 999 | 1,908 |
Director [Member] | ||
Advances from related party | $ 999 | $ 1,908 |
INCOME TAXES (Details)
INCOME TAXES (Details) - USD ($) | 12 Months Ended | |
Jan. 31, 2018 | Jan. 31, 2017 | |
INCOME TAX | ||
Net operating loss carryforward | $ 37,187 | $ 9,186 |
Tax Rate | 21.00% | 21.00% |
Deferred tax asset | $ 7,809 | $ 1,929 |
Less: Valuation allowance | (7,809) | (1,929) |
Deferred tax asset | $ 0 | $ 0 |
INCOME TAXES (Details Narrative
INCOME TAXES (Details Narrative) - USD ($) | 7 Months Ended | 12 Months Ended |
Jan. 31, 2017 | Jan. 31, 2018 | |
INCOME TAX | ||
Reduction in corporate tax rate description | The Act which includes a reduction in the corporate tax rate from 34% to 21% as well as other changes. | |
Valuation allowance increased | $ 5,880 | |
Valuation allowance | $ 1,929 | |
Ownership percentage | 50.00% | |
Net operating loss carryforwards expiration date | Which begin to expire between 2037 and 2038. | |
Net operating losses | $ 9,186 | $ 37,187 |